Synthetic lethality with BRAF/MEK inhibitors

Date 13 March 2015
Event ESMO Symposium on Signalling Pathways in Cancer 2015
Session Regulation of signalling pathway and therapeutic targeting
Topics Anticancer agents
Translational Research
Presenter Roderick Beijersbergen
Authors R. Beijersbergen
  • Netherlands Cancer Institute, 1066CX - Amsterdam/NL